Soluble CD127 potentiates IL‐7 activity in vivo in healthy mice

Abstract Introduction Soluble forms of cytokine receptors can be involved in the endogenous regulation of cytokine activity. Soluble interleukin 7 receptor α (sCD127) naturally binds IL‐7, therefore there is interest in its potential application as an immunotherapeutic agent to regulate IL‐7. With t...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Nawaf A. Aloufi, Alaa K. Ali, Stephanie C. Burke Schinkel, Bengisu Molyer, Priscila O. Barros, Joanne E. McBane, Seung‐Hwan Lee, Jonathan B. Angel
Formato: article
Lenguaje:EN
Publicado: Wiley 2021
Materias:
Acceso en línea:https://doaj.org/article/c0fcfa2918b042dda1c5bf3eaa964d74
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:c0fcfa2918b042dda1c5bf3eaa964d74
record_format dspace
spelling oai:doaj.org-article:c0fcfa2918b042dda1c5bf3eaa964d742021-11-12T19:57:15ZSoluble CD127 potentiates IL‐7 activity in vivo in healthy mice2050-452710.1002/iid3.530https://doaj.org/article/c0fcfa2918b042dda1c5bf3eaa964d742021-12-01T00:00:00Zhttps://doi.org/10.1002/iid3.530https://doaj.org/toc/2050-4527Abstract Introduction Soluble forms of cytokine receptors can be involved in the endogenous regulation of cytokine activity. Soluble interleukin 7 receptor α (sCD127) naturally binds IL‐7, therefore there is interest in its potential application as an immunotherapeutic agent to regulate IL‐7. With the hypothesis that sCD127 enhances IL‐7 activity, thus promoting T‐cell proliferation in vivo, we sought to assess the effect of sCD127, IL‐7 or IL‐7 + sCD127 treatment on CD4+ and CD8+ T‐cells in the blood and spleen of mice. Methods Peripheral blood mononuclear cells and splenocytes were prepared, and analyzed for T‐cell number, phenotype and proliferation (Ki67+) by flow cytometry. Results IL‐7 treatment induced T‐cell proliferation, increased T‐cell number, and triggered T‐cell differentiation each of which was enhanced with the addition of sCD127. IL‐7 + sCD127 treatment significantly increased spleen weight over that seen with IL‐7 treatment alone. More pronounced proliferation and a greater increase in cell number was observed in CD8+ T‐cells relative to the effect on CD4+ T‐cells. Conclusions These findings suggest that the addition of sCD127 enhances IL‐7‐mediated T‐cell proliferation and suggests a potential therapeutic use for sCD127.Nawaf A. AloufiAlaa K. AliStephanie C. Burke SchinkelBengisu MolyerPriscila O. BarrosJoanne E. McBaneSeung‐Hwan LeeJonathan B. AngelWileyarticleCD4+ T‐cellCD8+ T‐cellinterleukin‐7 (IL‐7)soluble IL‐7Rα (sCD127)T‐cell proliferationImmunologic diseases. AllergyRC581-607ENImmunity, Inflammation and Disease, Vol 9, Iss 4, Pp 1798-1808 (2021)
institution DOAJ
collection DOAJ
language EN
topic CD4+ T‐cell
CD8+ T‐cell
interleukin‐7 (IL‐7)
soluble IL‐7Rα (sCD127)
T‐cell proliferation
Immunologic diseases. Allergy
RC581-607
spellingShingle CD4+ T‐cell
CD8+ T‐cell
interleukin‐7 (IL‐7)
soluble IL‐7Rα (sCD127)
T‐cell proliferation
Immunologic diseases. Allergy
RC581-607
Nawaf A. Aloufi
Alaa K. Ali
Stephanie C. Burke Schinkel
Bengisu Molyer
Priscila O. Barros
Joanne E. McBane
Seung‐Hwan Lee
Jonathan B. Angel
Soluble CD127 potentiates IL‐7 activity in vivo in healthy mice
description Abstract Introduction Soluble forms of cytokine receptors can be involved in the endogenous regulation of cytokine activity. Soluble interleukin 7 receptor α (sCD127) naturally binds IL‐7, therefore there is interest in its potential application as an immunotherapeutic agent to regulate IL‐7. With the hypothesis that sCD127 enhances IL‐7 activity, thus promoting T‐cell proliferation in vivo, we sought to assess the effect of sCD127, IL‐7 or IL‐7 + sCD127 treatment on CD4+ and CD8+ T‐cells in the blood and spleen of mice. Methods Peripheral blood mononuclear cells and splenocytes were prepared, and analyzed for T‐cell number, phenotype and proliferation (Ki67+) by flow cytometry. Results IL‐7 treatment induced T‐cell proliferation, increased T‐cell number, and triggered T‐cell differentiation each of which was enhanced with the addition of sCD127. IL‐7 + sCD127 treatment significantly increased spleen weight over that seen with IL‐7 treatment alone. More pronounced proliferation and a greater increase in cell number was observed in CD8+ T‐cells relative to the effect on CD4+ T‐cells. Conclusions These findings suggest that the addition of sCD127 enhances IL‐7‐mediated T‐cell proliferation and suggests a potential therapeutic use for sCD127.
format article
author Nawaf A. Aloufi
Alaa K. Ali
Stephanie C. Burke Schinkel
Bengisu Molyer
Priscila O. Barros
Joanne E. McBane
Seung‐Hwan Lee
Jonathan B. Angel
author_facet Nawaf A. Aloufi
Alaa K. Ali
Stephanie C. Burke Schinkel
Bengisu Molyer
Priscila O. Barros
Joanne E. McBane
Seung‐Hwan Lee
Jonathan B. Angel
author_sort Nawaf A. Aloufi
title Soluble CD127 potentiates IL‐7 activity in vivo in healthy mice
title_short Soluble CD127 potentiates IL‐7 activity in vivo in healthy mice
title_full Soluble CD127 potentiates IL‐7 activity in vivo in healthy mice
title_fullStr Soluble CD127 potentiates IL‐7 activity in vivo in healthy mice
title_full_unstemmed Soluble CD127 potentiates IL‐7 activity in vivo in healthy mice
title_sort soluble cd127 potentiates il‐7 activity in vivo in healthy mice
publisher Wiley
publishDate 2021
url https://doaj.org/article/c0fcfa2918b042dda1c5bf3eaa964d74
work_keys_str_mv AT nawafaaloufi solublecd127potentiatesil7activityinvivoinhealthymice
AT alaakali solublecd127potentiatesil7activityinvivoinhealthymice
AT stephaniecburkeschinkel solublecd127potentiatesil7activityinvivoinhealthymice
AT bengisumolyer solublecd127potentiatesil7activityinvivoinhealthymice
AT priscilaobarros solublecd127potentiatesil7activityinvivoinhealthymice
AT joanneemcbane solublecd127potentiatesil7activityinvivoinhealthymice
AT seunghwanlee solublecd127potentiatesil7activityinvivoinhealthymice
AT jonathanbangel solublecd127potentiatesil7activityinvivoinhealthymice
_version_ 1718430340325834752